project id: TCGA-SKCM; case submitter id: TCGA-DA-A3F5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.4; age at index: 45; days to birth: -16701; days to death: 6873; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1949; age at diagnosis: 16701; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6826.0; icd 10 code: C77.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of head, face and neck; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1994; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 6217; days to sample procurement: 0; initial weight: 260.0; portion submitter id: TCGA-DA-A3F5-06A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;